Annual Non Current Assets
$4.60 M
-$3.21 M-41.08%
31 December 2023
Summary:
Inozyme Pharma annual long term assets is currently $4.60 million, with the most recent change of -$3.21 million (-41.08%) on 31 December 2023. During the last 3 years, it has fallen by -$13.79 million (-74.99%). INZY annual non current assets is now -74.99% below its all-time high of $18.38 million, reached on 31 December 2020.INZY Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$2.42 M
-$326.00 K-11.85%
30 September 2024
Summary:
Inozyme Pharma quarterly long term assets is currently $2.42 million, with the most recent change of -$326.00 thousand (-11.85%) on 30 September 2024. Over the past year, it has dropped by -$2.42 million (-49.98%). INZY quarterly non current assets is now -86.81% below its all-time high of $18.38 million, reached on 31 December 2020.INZY Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.1% | -50.0% |
| 3 y3 years | -75.0% | -66.2% |
| 5 y5 years | +1565.6% | - |
INZY Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -75.0% | at low | -71.0% | at low |
| 5 y | 5 years | -75.0% | +1565.6% | -86.8% | +400.8% |
| alltime | all time | -75.0% | +1565.6% | -86.8% | +400.8% |
Inozyme Pharma Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.42 M(-11.9%) |
| June 2024 | - | $2.75 M(+5.0%) |
| Mar 2024 | - | $2.62 M(-43.0%) |
| Dec 2023 | $196.25 M(+49.4%) | $4.60 M(-5.1%) |
| Sept 2023 | - | $4.85 M(-34.0%) |
| June 2023 | - | $7.34 M(-4.0%) |
| Mar 2023 | - | $7.65 M(-2.0%) |
| Dec 2022 | $131.39 M | $7.80 M(-3.6%) |
| Sept 2022 | - | $8.10 M(-1.8%) |
| June 2022 | - | $8.24 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $8.35 M(+1.8%) |
| Dec 2021 | $115.34 M(-23.6%) | $8.20 M(+14.4%) |
| Sept 2021 | - | $7.17 M(-1.8%) |
| June 2021 | - | $7.30 M(-32.9%) |
| Mar 2021 | - | $10.87 M(-40.9%) |
| Dec 2020 | $150.98 M(+218.1%) | $18.38 M(+22.4%) |
| Sept 2020 | - | $15.02 M(+289.9%) |
| June 2020 | - | $3.85 M(+398.2%) |
| Mar 2020 | - | $773.00 K(+59.7%) |
| Dec 2019 | $47.46 M(+9.7%) | $484.00 K |
| Dec 2018 | $43.27 M | - |
FAQ
- What is Inozyme Pharma annual long term assets?
- What is the all time high annual non current assets for Inozyme Pharma?
- What is Inozyme Pharma annual non current assets year-on-year change?
- What is Inozyme Pharma quarterly long term assets?
- What is the all time high quarterly non current assets for Inozyme Pharma?
- What is Inozyme Pharma quarterly non current assets year-on-year change?
What is Inozyme Pharma annual long term assets?
The current annual non current assets of INZY is $4.60 M
What is the all time high annual non current assets for Inozyme Pharma?
Inozyme Pharma all-time high annual long term assets is $18.38 M
What is Inozyme Pharma annual non current assets year-on-year change?
Over the past year, INZY annual long term assets has changed by -$3.21 M (-41.08%)
What is Inozyme Pharma quarterly long term assets?
The current quarterly non current assets of INZY is $2.42 M
What is the all time high quarterly non current assets for Inozyme Pharma?
Inozyme Pharma all-time high quarterly long term assets is $18.38 M
What is Inozyme Pharma quarterly non current assets year-on-year change?
Over the past year, INZY quarterly long term assets has changed by -$2.42 M (-49.98%)